Calvo-Pinilla, E., de la Poza, F., Gubbins, S., Mertens, P. P. C., Ortego, J., & Castillo-Olivares, J. (2015). Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge. Antiviral Res.

Calvo-Pinilla, Eva, Francisco de la Poza, Simon Gubbins, Peter Paul Clement Mertens, Javier Ortego, and Javier Castillo-Olivares. "Antiserum From Mice Vaccinated With Modified Vaccinia Ankara Virus Expressing African Horse Sickness Virus (AHSV) VP2 Provides Protection When It Is Administered 48 h Before, or 48 h After Challenge." Antiviral Res 2015.

Calvo-Pinilla, Eva, et al. "Antiserum From Mice Vaccinated With Modified Vaccinia Ankara Virus Expressing African Horse Sickness Virus (AHSV) VP2 Provides Protection When It Is Administered 48 h Before, or 48 h After Challenge." Antiviral Res 2015.